Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Endocrine|September 6, 2022
Integrated bioinformatics analysis and screening of hub genes in polycystic ovary syndromeGan Qiao, Jinshan Xing, Xin Luo, et al.
International Journal of Biological Sciences|October 21, 2021
Enolase 1, a Moonlighting Protein, as a Potential Target for Cancer TreatmentGan Qiao, Anguo Wu, Xiaoliang Chen, et al.
Cells|June 11, 2025
Progranulin's Protective Mechanisms and Therapeutic Potential in Cardiovascular DiseaseGan Qiao, Yongxiang Lu, Jianping Wu, et al.
Proteomes|November 24, 2025
Identification of Protein Markers for Chronic Ischemic Heart Disease Through Integrated Analysis of the Human Plasma Proteome and Genome-Wide Association DataChunyang Ren, Gan Qiao, Jianping Wu, et al.
Bioengineering & Translational Medicine|May 19, 2023
Micelle encapsulation zinc-doped copper oxide nanocomposites reverse Olaparib resistance in ovarian cancer by disrupting homologous recombination repairJingyan Yi, Xin Luo, Jinshan Xing, et al.
Cells|September 26, 2025
Empagliflozin Preserves Cardiomyocyte Structural Homeostasis via the Stabilization of the Integrin α5-Desmocollin-2 Adhesion Axis in Sepsis-Induced CardiomyopathyGan Qiao, Yongxiang Lu, Jianping Wu, et al.
Biochimica Et Biophysica Acta. General Subjects|October 10, 2020
Protein kinases as targets for developing anticancer agents from marine organismsGan Qiao, Kangping Bi, Junhong Liu, et al.
Oncology Letters|March 20, 2026
Erratum: [Corrigendum] Inhibition of Rac1 reverses enzalutamide resistance in castration-resistant prostate cancerXiaoliang Chen, Lili Yin, Gan Qiao, et al.
Recent Patents on Anti-Cancer Drug Discovery|February 1, 2020
Alkaloids as Anticancer Agents: A Review of Chinese Patents in Recent 5 YearsHongyu Tao, Ling Zuo, Huanli Xu, et al.
Oncology Letters|August 13, 2020
Inhibition of Rac1 reverses enzalutamide resistance in castration-resistant prostate cancerXiaoliang Chen, Lili Yin, Gan Qiao, et al.
Pageof 5